Brief: Rua Bioscience Posts FY Revenue NZD 320 Thousand
29/08/2024 01:40
Aug 29 (Reuters) - Rua Bioscience FY pretax profit NZD -13.72 million. * FY revenue NZD 320 thousand
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth